YONG LI to Combined Modality Therapy
This is a "connection" page, showing publications YONG LI has written about Combined Modality Therapy.
Connection Strength
0.059
-
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies. J Immunother Cancer. 2019 10 22; 7(1):272.
Score: 0.030
-
Neoantigen vaccine: an emerging tumor immunotherapy. Mol Cancer. 2019 08 23; 18(1):128.
Score: 0.030